company background image
506260 logo

Anuh Pharma BSE:506260 Stock Report

Last Price

₹223.15

Market Cap

₹10.9b

7D

-1.3%

1Y

98.1%

Updated

23 Jul, 2024

Data

Company Financials

Anuh Pharma Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anuh Pharma
Historical stock prices
Current Share Price₹223.15
52 Week High₹265.00
52 Week Low₹106.55
Beta0.62
11 Month Change-1.87%
3 Month Change-5.46%
1 Year Change98.09%
33 Year Change58.94%
5 Year Change268.39%
Change since IPO1,173.94%

Recent News & Updates

Recent updates

Shareholder Returns

506260IN PharmaceuticalsIN Market
7D-1.3%-0.6%-1.5%
1Y98.1%47.4%43.8%

Return vs Industry: 506260 exceeded the Indian Pharmaceuticals industry which returned 47.4% over the past year.

Return vs Market: 506260 exceeded the Indian Market which returned 43.8% over the past year.

Price Volatility

Is 506260's price volatile compared to industry and market?
506260 volatility
506260 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 506260 has not had significant price volatility in the past 3 months.

Volatility Over Time: 506260's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1960159Ritesh Shahwww.anuhpharma.com

Anuh Pharma Limited manufactures and sells bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and intermediates. The company also provides corticosteroids, such as anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, and anti-histamines.

Anuh Pharma Limited Fundamentals Summary

How do Anuh Pharma's earnings and revenue compare to its market cap?
506260 fundamental statistics
Market cap₹10.94b
Earnings (TTM)₹600.58m
Revenue (TTM)₹6.47b

18.6x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506260 income statement (TTM)
Revenue₹6.47b
Cost of Revenue₹4.87b
Gross Profit₹1.60b
Other Expenses₹1.00b
Earnings₹600.58m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)11.98
Gross Margin24.78%
Net Profit Margin9.28%
Debt/Equity Ratio0.7%

How did 506260 perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

21%

Payout Ratio

Does 506260 pay a reliable dividends?

See 506260 dividend history and benchmarks
When do you need to buy 506260 by to receive an upcoming dividend?
Anuh Pharma dividend dates
Ex Dividend DateAug 16 2024
Dividend Pay DateSep 22 2024
Days until Ex dividend23 days
Days until Dividend pay date60 days

Does 506260 pay a reliable dividends?

See 506260 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.